ritonavir and Colitis--Ulcerative

ritonavir has been researched along with Colitis--Ulcerative* in 1 studies

Other Studies

1 other study(ies) available for ritonavir and Colitis--Ulcerative

Article	Year
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir. Disease models & mechanisms, 2018, 11-21, Volume: 11, Issue:11 Glucose is the preferred source of energy in activated inflammatory cells. Glucose uptake into the cell is ensured by a family of glucose uptake transporters (GLUTs), which have been identified as off-target molecules of the HIV protease inhibitor ritonavir. In this study, we examined the effect of ritonavir on inflammation Topics: Adult; Aged, 80 and over; Animals; Aspartic Acid; Biomarkers; CD4-Positive T-Lymphocytes; Colitis, Ulcerative; Disease Models, Animal; Female; Glucose; Glutamic Acid; Humans; Inflammation; Leukocytes; Male; Middle Aged; Phenotype; Principal Component Analysis; Ritonavir	2018

Article

Year

Targeting ulcerative colitis by suppressing glucose uptake with ritonavir.

Disease models & mechanisms, 2018, 11-21, Volume: 11, Issue:11

Glucose is the preferred source of energy in activated inflammatory cells. Glucose uptake into the cell is ensured by a family of glucose uptake transporters (GLUTs), which have been identified as off-target molecules of the HIV protease inhibitor ritonavir. In this study, we examined the effect of ritonavir on inflammation

Topics: Adult; Aged, 80 and over; Animals; Aspartic Acid; Biomarkers; CD4-Positive T-Lymphocytes; Colitis, Ulcerative; Disease Models, Animal; Female; Glucose; Glutamic Acid; Humans; Inflammation; Leukocytes; Male; Middle Aged; Phenotype; Principal Component Analysis; Ritonavir

2018